Korea’s medical tourism boom now runs through two travel and beauty platforms as much as through its hospitals. Maeil Business Newspaper reported that medical tourism consumption in Korea rose 5.8 times to 491.1 billion won in the first quarter of this year, up from 84.15 billion won in the same quarter of 2019, driven by demand for K-beauty. That growth came even as foreign tourist spending slowed overall, with medical and wellness travel helping to improve the country’s tourism balance. It has also pulled platforms such as MyReal Trip and Healing Paper deeper into the business of serving foreign patients.
Korea’s medical tourism runs on K-beauty demand
Maeil Business Newspaper reported that the Ministry of Health and Welfare recorded about 2.01 million foreign patients in Korea last year, part of a climb the ministry traces from 610,000 in 2023 to 1.17 million in 2024. Since 2009, the cumulative number of foreign patients has reached 7.06 million. Demand concentrates heavily in K-beauty medical care, meaning dermatology and plastic surgery, alongside wellness experiences. That concentration is worth naming plainly, because it defines both the opportunity and the exposure.
K-beauty medical care is cosmetic tourism, which sits across the line between medical and wellness travel. These procedures are medically performed, in clinics and by clinicians, but the motivation is aesthetic rather than the treatment of illness. That places Korea’s boom in a segment judged on visible results and on trust as much as on clinical outcomes. When demand runs this hard through a single category, the destination inherits that category’s volatility, because aesthetic demand tracks fashion, social media and disposable income far more than a hip replacement ever will. Korea’s 5.8-fold jump is real, and its dependence on one driver is the risk that sits underneath it.
MyReal Trip moves from travel into beauty and wellness
Maeil Business Newspaper reported that MyReal Trip, a domestic travel platform, has launched lifestyle categories covering beauty and wellness, letting users browse beauty and wellness products the way they already book travel. It applies the partner-verification criteria it uses in travel to the new categories, and recommends products from user behaviour data. A ‘beauty check-in’ promotion running until the 20th of the month spans pre-travel preparation and post-return recovery across themed offerings from spas and aesthetics to hair and nails. The platform intends to build the categories for domestic users first, then extend them to K-wellness experiences for foreign visitors to Korea. It pointed to Korea Tourism Data Lab figures projecting a 40.4 per cent year-on-year rise in foreigner spending in the beauty and health sector in 2025.
This is a facilitator widening its remit, and the direction matters more than the promotion. The standing critique of medical travel facilitators is that many sell visibility rather than trust, ranking clinics that pay rather than clinics that perform, and leaving the patient to carry the risk. A platform that extends its own partner-verification into beauty and wellness is at least gesturing at the harder job, which is vetting. Whether MyReal Trip’s curation reduces the information asymmetry a foreign patient faces, or simply repackages a booking funnel with a wellness label, is the question its foreign-visitor expansion will answer.
Healing Paper adds interpretation for foreign patients
Maeil Business Newspaper reported that Healing Paper, which runs a global K-beauty medical platform, has strengthened its support for foreign patients by adding an offline interpretation function to its one-to-one guidance service. That extends the platform’s help from booking assistance into hospital visits and direct communication on site. The service is built to reduce language barriers and information asymmetry for foreign patients. It covers the whole path from choosing a procedure and a hospital through to the reservation, and pairs a counselling function with interpretation. Hong Seung-il, chief executive of Healing Paper, said the aim is to build “a standardized K-beauty medical experience” that satisfies both patients and hospitals.
Interpretation and on-site guidance address the two risks that hurt cosmetic patients most, and neither is clinical. The first is the language barrier, which turns consent, aftercare instructions and complication management into guesswork when the patient and the clinician do not share a language. The second is continuity of care, the gap that opens when a patient flies home days after a procedure with no clear route back to the clinic that performed it. A facilitator that puts an interpreter in the room and stays involved through the hospital visit is working on the continuity-of-care risk directly, which is a more useful contribution than another discovery app. The value of these platforms will be judged on whether foreign patients are better protected, not on how many bookings they process.
What This Means
Korea’s medical tourism has grown 5.8 times in a single quarter on the strength of K-beauty, and the response from MyReal Trip and Healing Paper shows where the competition is moving, which is away from pure booking and toward interpretation, verification and end-to-end support for foreign patients. That is the right direction, because cosmetic tourism lives or dies on trust and continuity, and platforms that reduce language and information risk earn a place the clinics cannot fill alone. The exposure is the concentration. A boom carried this heavily by one category, K-beauty, rises fast and can fall fast, and the platforms betting on it are betting on aesthetic demand holding. The signal I would watch is not the next consumption figure but the mix, meaning whether Korea’s foreign-patient growth broadens beyond dermatology and plastic surgery. A medical tourism sector resting on one driver is only as durable as that driver’s fashion.
